I agree that this site is using cookies. You can find further informations here.
X
Marasca, C.
145  results:
Search for persons X
?
1

Secukinumab in Hidradenitis Suppurativa Patients Who Failed..:

Martora F ; Marasca C ; Cacciapuoti S...
https://www.dovepress.com/secukinumab-in-hidradenitis-suppurativa-patients-who-failed-adalimumab-peer-reviewed-fulltext-article-CCID.  , 2024
Link: https://doaj.org/article..
 
?
2

Long‐term efficacy and safety of zanubrutinib (ZANU) in rel..:

Trotman, J. ; Tedeschi, A. ; Hu, B....
Hematological Oncology.  41 (2023)  S2 - p. 390-392 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Adalimumab, Ustekinumab, and Secukinumab in the Management ..:

Martora F ; Megna M ; Battista T...
https://www.dovepress.com/adalimumab-ustekinumab-and-secukinumab-in-the-management-of-hidradenit-peer-reviewed-fulltext-article-CCID.  , 2023
Link: https://doaj.org/article..
 
?
4

Friedman tongue position and the anthropometric parameters ..:

Luzzi V ; Altieri F ; Guaragna M...
info:eu-repo/semantics/altIdentifier/pmid/36833949.  , 2023
Link: https://hdl.handle.net/1..
 
?
5

Role of Notch2 pathway in mature B cell malignancies:

Mesini N ; Fiorcari S ; Atene C. G...
info:eu-repo/semantics/altIdentifier/pmid/36686759.  , 2023
Link: https://hdl.handle.net/1..
 
?
6

Early palliative care versus usual haematological care in m..:

Giusti D ; Colaci E ; Pioli V...
info:eu-repo/semantics/altIdentifier/pmid/37751995.  , 2023
Link: https://hdl.handle.net/1..
 
?
7

Reply to 'A case of dystrophic epidermolysis bullosa prurig..:

Martora, F. ; Fabbrocini, G. ; Nappa, P....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  9 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
8

Reply to 'Cutaneous adverse effects of the available COVID‐..:

Potestio, L. ; Genco, L. ; Villani, A....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  11 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
9

Genetic and Phenotypic Attributes of Splenic Marginal Zone ..:

Bonfiglio, Ferdinando ; Bruscaggin, Alessio ; Guidetti, Francesca...
info:eu-repo/semantics/altIdentifier/pmid/34653238.  , 2022
Link: http://hdl.handle.net/24..
 
?
10

Efficacy of Front-Line Ibrutinib and Rituximab Combination ..:

Mauro F. R ; Paoloni F ; Molica S...
info:eu-repo/semantics/altIdentifier/pmid/35008372.  , 2022
Link: https://hdl.handle.net/1..
 
?
11

The Role of T Cell Immunity in Monoclonal Gammopathy and Mu..:

Lagreca I ; Riva G ; Nasillo V...
info:eu-repo/semantics/altIdentifier/pmid/35563634.  , 2022
Link: http://hdl.handle.net/11..
 
?
12

BTK Inhibitors Impair Platelet-Mediated Antifungal Activity:

Nasillo V ; Lagreca I ; Vallerini D...
info:eu-repo/semantics/altIdentifier/pmid/35326454.  , 2022
Link: http://hdl.handle.net/11..
 
?
13

Genetic and phenotypic attributes of splenic marginal zone ..:

Bonfiglio F ; Bruscaggin A ; Guidetti F...
info:eu-repo/semantics/altIdentifier/pmid/34653238.  , 2022
Link: http://hdl.handle.net/11..
 
?
14

Notch2 Increases the Resistance to Venetoclax-Induced Apopt..:

Fiorcari S ; Maffei R ; Atene C. G...
info:eu-repo/semantics/altIdentifier/pmid/35070982.  , 2022
Link: http://hdl.handle.net/11..
 
?
15

Efficacy of Front-Line Ibrutinib and Rituximab Combination ..:

Mauro F. R ; Paoloni F ; Molica S...
info:eu-repo/semantics/altIdentifier/wos/WOS:000771433100001.  , 2022
Link: http://hdl.handle.net/11..
 
1-15